Gujarat Themis Biosyn (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Gujarat Themis Biosyn Limited |
|||
|
Price: ₹314.40 (-0.28%) | ||
| 52 Week Low: ₹253.50 52 Week High: ₹530.00 |
|||
| Market Capital: 442.83 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Gujarat Themis Biosyn Share Price Target For 2025
- 1.1.1: Gujarat Themis Biosyn Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Gujarat Themis Biosyn Share Price Target For 2026
- 1.2.1: Gujarat Themis Biosyn Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Gujarat Themis Biosyn Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Gujarat Themis Biosyn Financial Performance
- 3.0.1: Is Gujarat Themis Biosyn A Good Buy For Long Term?
Gujarat Themis Biosyn, a Small Cap company has delivered 2805.7% returns in 5-year with 75.5% profit margin, making it a potential Multibagger.
To predict the Gujarat Themis Biosyn's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Gujarat Themis Biosyn Share Price Target For 2025
The line chart displays the monthly closing prices of Gujarat Themis Biosyn with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gujarat Themis Biosyn shares in 2025, see the table below.
Gujarat Themis Biosyn Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 364.88 (+16.05%) | Price Action: 27 Feb 2024 High |
| 2025 Target 2 | 360.08 (+14.52%) | Price Action: 13 Mar 2024 Low |
| 2025 Target 1 | 356.5 (+13.39%) | Price Action: 11 Sep 2024 High |
| Current Price | 314.40 | Gujarat Themis Biosyn's share price as of 23 Jan 2025 |
| Stop Loss 1 | 295.5 (-6.02%) | Price Action: 13 Jan 2025 Low |
| Stop Loss 2 | 292.47 (-6.98%) | Price Action: 04 Jan 2024 High |
| Stop Loss 3 | 288.0 (-8.4%) | Price Action: 13 Nov 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Gujarat Themis Biosyn is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹318.66 serves as the nearest technical reference point.
Historical Returns: 3-month: +13.05% | 6-month: -5.13% | 1-year: -6.54%
Gujarat Themis Biosyn Share Price Target For 2026
The line chart displays the monthly closing prices of Gujarat Themis Biosyn with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gujarat Themis Biosyn shares in 2026, see the table below.
Gujarat Themis Biosyn Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 599.35 (+90.63%) | Price Action: Chart |
| 2026 Target 2 | 588.17 (+87.07%) | Price Action: Chart |
| 2026 Target 1 | 582.35 (+85.22%) | Fibonacci Extension Level 64.90% |
| Current Price | 314.40 | Gujarat Themis Biosyn's share price as of 23 Jan 2025 |
| Stop Loss 1 | 236.15 (-24.89%) | Price Action: 27 Dec 2023 High |
| Stop Loss 2 | 233.39 (-25.77%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 3 | 229.19 (-27.11%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Gujarat Themis Biosyn is currently trading near its 52-week low of ₹253.5, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -6.54% | 3-year: +269.14% | 5-year: +2,805.73%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Gujarat Themis Biosyn Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹314.40 | ||
| 2025 | ₹540.32 | +71.85% | ₹548.42 |
| 2026 | ₹800.46 | +48.14% | ₹812.47 |
| 2027 | ₹1,173.84 | +46.64% | ₹1,191.45 |
| 2028 | ₹1,566.21 | +33.42% | ₹1,589.70 |
| 2029 | ₹2,164.94 | +38.22% | ₹2,197.41 |
| 2030 | ₹3,119.97 | +44.11% | ₹3,166.77 |
| 2031 | ₹4,170.57 | +33.67% | ₹4,233.13 |
| 2032 | ₹5,184.38 | +24.3% | ₹5,262.15 |
| 2033 | ₹7,181.25 | +38.51% | ₹7,288.97 |
| 2034 | ₹9,548.91 | +32.97% | ₹9,692.14 |
| 2035 | ₹12,375.42 | +29.6% | ₹12,561.05 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Gujarat Themis Biosyn Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 442.83 Crore | Market valuation of Gujarat Themis Biosyn's shares. |
| Revenue (TTM) | 169.8 Crore | Total revenue generated by Gujarat Themis Biosyn over the past twelve months. |
| Net Income (TTM) | +59.16 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +46.8% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +75.48% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-10.59% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.01 | Company's total debt divided by total shareholder equity. |
| Total Debt | 3.39 Crore | Sum of Gujarat Themis Biosyn's current & long-term financial obligations. |
Is Gujarat Themis Biosyn A Good Buy For Long Term?
Gujarat Themis Biosyn, a small-cap stock with a market capitalization of ₹442.83 crore, shows mixed signals for long-term investment. While its impressive 5-year return of 906.29% and a robust profit margin of 75.49% (TTM net profit ₹59.16 crore on ₹169.8 crore revenue) are positive, recent performance is concerning. The stock's -37.25% return over the past three months and a 10.59% revenue decline quarter-over-quarter raise serious concerns. Given this volatility, coupled with a relatively low debt of ₹3.39 crore, it's currently not a good buy for long-term investors. Further analysis is recommended before considering any investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
